Nitrous oxide 50%

DRUG2 trials

Sponsors

Columbia University, Washington University School of Medicine

Conditions

Depressive Disorder, MajorDepressive Disorder, Treatment-ResistantSickle Cell DiseaseVaso-occlusive Crisis

Phase 2

Nitrous Oxide Analgesia Vaso-occlusive Crisis

CompletedNCT01891812

Columbia UniversitySickle Cell Disease, Vaso-occlusive Crisis

Start: 2013-11-12End: 2018-01-19Updated: 2026-01-28

Inhaled Nitrous Oxide for Treatment-Resistant Depression: Optimizing Dosing Strategies

CompletedNCT03283670

Washington University School of MedicineDepressive Disorder, Major, Depressive Disorder, Treatment-Resistant

Start: 2016-11-22End: 2020-02-18Updated: 2022-04-04

Related Papers

A phase 2 trial of inhaled nitrous oxide for treatment-resistant major depression.

2021-06-0166 citations